Evotec SE Stock OTC Markets
Stocks
EVOTF
DE0005664809
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
16:19:37 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 3.890 USD | -41.85% |
|
-.--% | -51.43% |
| 09-02 | Evotec, Plectonic Launch Research Collaboration on New T-Cell Approaches for Solid Tumors | MT |
| 09-02 | Evotec, Plectonic Biotech Partner on Research of Novel Immunotherapy for Solid Tumors | MT |
| Market Cap | 571M 663M 537M 491M 917M 62.63B 920M 6.34B 2.46B 32.1B 2.49B 2.43B 104B | P/E 2026 * |
-2.74x | P/E 2027 * | -7.47x |
|---|---|---|---|---|---|
| Enterprise Value | 714M 829M 671M 613M 1.15B 78.3B 1.15B 7.93B 3.07B 40.13B 3.11B 3.04B 130B | EV / Sales 2026 * |
1.19x | EV / Sales 2027 * | 1.01x |
| Free-Float |
89.91% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Xetra
| EVT | Delayed | |
Tradegate
| EVT | Real-time | |
|
CBOE
| EVTd | Real-time | |
|
Boerse Muenchen
| EVT | Real-time | |
|
Börse Stuttgart
| EVT | Delayed | |
|
Borsa Italiana
| 1EVT | End-of-day quote | |
|
Deutsche Boerse AG
| EVT | Delayed | |
|
Bulgaria S.E.
| EVT | End-of-day quote | |
|
OTC Markets
| EVOTF | Delayed | |
|
Wiener Boerse
| EVT | End-of-day quote | |
|
London S.E.
| 0IRF | Delayed | |
|
CBOE
| 0IRF | Real-time | |
|
Swiss Exchange
| EVT | Delayed |
Last Transcript : Evotec SE
| 1 day | -41.85% | ||
| 1 month | -41.85% | ||
| 3 months | -41.85% | ||
| 6 months | -37.35% | ||
| Current year | -51.43% |
| 1 month | 3.89 |  | 3.89 |
| Current year | 3.89 | | 6.69 |
| 1 year | 3.89 | | 8.36 |
| 3 years | 3.89 | | 24.61 |
| 5 years | 3.89 | | 52.21 |
| 10 years | 3.89 | | 52.21 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 2024-06-30 | |
| Director of Finance/CFO | - | 2026-04-30 | |
Ingrid Müller
COO | Chief Operating Officer | - | 2026-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Roland Sackers
BRD | Director/Board Member | 58 | 2019-06-18 |
| Director/Board Member | 64 | 2021-05-31 | |
Duncan McHale
BRD | Director/Board Member | 59 | 2024-06-09 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -41.85% | -.--% | - | - | 663M | |
| -2.54% | -2.84% | -1.77% | +14.72% | 48.93B | |
| -0.40% | +1.03% | +418.57% | +523.39% | 45.01B | |
| -1.42% | +2.30% | +42.67% | +21.22% | 44.07B | |
| -1.22% | -2.31% | +4.82% | +74.90% | 40.73B | |
| +0.53% | -1.36% | +16.87% | +47.12% | 33.52B | |
| -0.21% | +9.14% | - | - | 17.77B | |
| -0.35% | -1.56% | +21.42% | +123.04% | 16.5B | |
| -1.01% | +0.50% | +13.91% | +31.45% | 14.67B | |
| -1.65% | -1.03% | +75.93% | +41.22% | 13.77B | |
| Average | -5.01% | +0.53% | +74.05% | +109.63% | 30.55B | |
| Weighted average by Cap. | -1.13% | +0.11% | +89.42% | +127.93% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 601M 698M 565M 516M 965M 65.92B 968M 6.68B 2.59B 33.78B 2.62B 2.56B 109B | 724M 841M 681M 622M 1.16B 79.44B 1.17B 8.05B 3.12B 40.71B 3.16B 3.09B 131B |
| Net income | -202M -235M -190M -174M -324M -22.16B -326M -2.24B -870M -11.36B -880M -861M -36.65B | -48.25M -56.03M -45.39M -41.46M -77.51M -5.29B -77.76M -536M -208M -2.71B -210M -206M -8.76B |
| Net Debt | 143M 166M 134M 123M 229M 15.67B 230M 1.59B 615M 8.03B 623M 609M 25.92B | 162M 188M 153M 139M 261M 17.79B 261M 1.8B 698M 9.12B 707M 691M 29.43B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EVT Stock
- EVOTF Stock
Select your edition
All financial news and data tailored to specific country editions
